In 1978, my mother, Barbara Harman, then 58, had a lump removed from her breast at Queen Alexandra Hospital in Portsmouth.
In June of that year, she was prescribed tamoxifen, the drug recently promoted by pharmacologist Craig Jordan. She was told it was a new form of treatment and she was monitored regularly until the mid-1990s. The cancer did not return. She died 43 years later at the age of 101.